营养不良作为妇科癌症术后并发症风险因素:基于国家手术结局数据库的分析
利用NSQIP数据库分析2005至2019年间76290例卵巢、子宫或宫颈癌手术患者,评估不同营养不良定义与术后30天主要并发症、再入院和再手术的关联。卵巢癌中ESPEN2定义、子宫癌中ACS定义、宫颈癌中白蛋白<3.5 g/dL分别与不良结局相关。作者认为术前风险评估可按癌症特异性营养不良标准定制。
要点
- 卵巢癌中ESPEN2营养不良与再入院风险比1.69、再手术2.53、并发症1.36相关。
- 子宫癌中ACS营养不良与再入院风险比2.74、再手术3.61、并发症3.92相关。
- 宫颈癌中白蛋白<3.5 g/dL与再入院风险比1.48、再手术2.25、并发症2.59相关。
核心结论
- 术前风险评估可能使用癌症特异性营养不良标准进行定制。
- 卵巢癌中ESPEN2定义、子宫癌中ACS定义以及所有癌症中白蛋白<3.5 g/dL均与主要并发症、再入院和再手术相关。
研究设计与样本
- 使用国家手术质量改进计划(NSQIP)数据库识别2005年至2019年间接受卵巢、子宫或宫颈癌切除术的患者。
- 共纳入76290例接受手术的患者,按预设营养不良标准分类:严重营养不良(BMI<18.5且10%体重丢失)、ESPEN1(BMI 18.5-22且10%体重丢失)、ESPEN2(BMI<18.5)、ACS(正常/超重BMI且10%体重丢失)、轻度营养不良(BMI 18.5-22)或白蛋白<3.5 g/dL。
- 采用改良泊松回归估计各定义与结局的关联。
主要发现
- 符合营养不良定义的患者数:严重营养不良98例(0.1%)、ESPEN1 148例(0.2%)、ESPEN2 877例(1.1%)、ACS 1028例(1.3%)、轻度营养不良2853例(3.7%)、白蛋白<3.5 g/dL占11.1%。
- 总体并发症率:非计划再入院5.5%、再手术1.7%、主要并发症13.5%。
- 卵巢癌中ESPEN2营养不良与再入院风险比1.69(95%CI 1.29-2.20)、再手术2.53(95%CI 1.70-3.77)、并发症1.36(95%CI 1.20-1.54)相关。
- 子宫癌中ACS营养不良与再入院风险比2.74(95%CI 2.09-3.59)、再手术3.61(95%CI 2.29-5.71)、并发症3.92(95%CI 3.40-4.53)相关。
- 宫颈癌中白蛋白<3.5 g/dL与再入院风险比1.48(95%CI 1.01-2.19)、再手术2.25(95%CI 1.17-4.34)、并发症2.59(95%CI 2.11-3.17)相关。
关键数值与推荐
- 严重营养不良定义:BMI<18.5且10%体重丢失(98例,0.1%)。
- ESPEN1定义:BMI 18.5-22且10%体重丢失(148例,0.2%)。
- ESPEN2定义:BMI<18.5(877例,1.1%)。
- ACS定义:正常/超重BMI且10%体重丢失(1028例,1.3%)。
- 轻度营养不良定义:BMI 18.5-22(2853例,3.7%);白蛋白<3.5 g/dL占11.1%。
临床怎么用
- 作者认为术前风险评估可能使用癌症特异性营养不良标准进行定制。
- 原文未据此给出具体临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess, using a national surgical outcomes database, the association of various malnutrition definitions with post-operative morbidity in three gynecologic malignancies. METHODS: Patients undergoing resection of ovarian, uterine, or cervical cancer between 2005 and 2019 were identified using the National Surgical Quality Improvement Program (NSQIP) database. Patients were classified based on specific, pre-defined malnutrition criteria: severe malnutrition (Body Mass Index (BMI) <18.5 + 10% weight loss), European Society for Clinical Nutrition and Metabolism ((ESPEN1); BMI 18.5-22 + 10% weight loss), ESPEN2 (BMI < 18.5), American Cancer Society ((ACS); normal/overweight BMI + 10% weight loss), mild malnutrition (BMI 18.5-22), or albumin (<3.5 g/dL). Outcomes included 30-day major complications, readmission, reoperation. Modified Poisson regression estimated associations between definitions and outcomes. RESULTS: Of 76,290 total patients undergoing surgery, those meeting malnutrition definitions were: severe-98 (0.1%), ESPEN1-148 (0.2%), ESPEN2-877 (1.1%), ACS-1028 (1.3%), mild-2853 (3.7%), and albumin (11.1%). Complication rates were: unplanned readmission-5.5%, reoperation-1.7%, major complications-13.5%. For ovarian cancer, ESPEN2 malnutrition was associated with higher readmissions (risk ratio 1.69; 95% confidence interval 1.29-2.20), reoperations (2.53; 1.70-3.77), and complications (1.36; 1.20-1.54). For uterine cancer, ACS malnutrition was associated with readmissions (2.74; 2.09-3.59), reoperations (3.61; 2.29-5.71) and complications (3.92; 3.40-4.53). For cervical cancer, albumin<3.5 g/dL was associated with readmissions (1.48; 1.01-2.19), reoperations (2.25; 1.17-4.34), and complications (2.59; 2.11-3.17). Albumin<3.5 was associated with adverse outcomes in ovarian and uterine cancer. CONCLUSIONS: Preoperative risk assessments might be tailored using cancer-specific malnutrition criteria. Major complications, readmissions, and reoperations are all associated with the ESPEN2 definition for ovarian cancer, the ACS definition for uterine cancer, and with albumin<3.5 for all cancers.
引用
- Goins EC, Weber JM, Truong T, et al. Malnutrition as a risk factor for post-operative morbidity in gynecologic cancer: Analysis using a national surgical outcomes database. Gynecol Oncol. 2022. PMID: 35241292. doi:10.1016/j.ygyno.2022.01.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。